stockportfolio.pro
GH vs INSM: Which Stock Is the Better Buy?
Guardant Health, Inc. and Insmed Incorporated side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
AI verdict — GH vs INSM, read from the filings
The stronger business, the cheaper stock, and the risks — synthesised from both companies’ SEC filings, every figure computed not guessed. Not investment advice.
| Guardant Health, Inc. (GH) | Insmed Incorporated (INSM) | |
|---|---|---|
| Market cap | $17.4B | $20.9B |
| Revenue (latest FY) | $982.02M | $606.42M |
| Net income (latest FY) | $-416.28M | $-1.28B |
| Revenue growth (5y CAGR) | 27.9% | 29.8% |
| Net margin | -42.4% | -210.5% |
| Return on equity | 419.2% | -172.8% |
| P/E ratio | — | — |
| Dividend yield | — | — |
| Profitable years (of last 10) | 0 | 0 |
| Positive free cash flow | No | No |
See the full GH vs INSM breakdown
Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.
Open GH's full financials → Open INSM's full financials →More comparisons
Frequently asked questions
Which is bigger, GH or INSM?
Insmed Incorporated is larger by market capitalization — $20.9B versus $17.4B.
Which grows faster, GH or INSM?
Over the last five fiscal years, Insmed Incorporated grew revenue faster — 29.8%/yr versus 27.9%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.